$ETST has chosen to target diseases for which, the benefits of CBD have already been demonstrated by different groups of researchers around the world. However, it is through ETST’s first in vitro study that results confirm the effectiveness of CBD on breast cancer, immune cell function, and human brain cells by acting as a neuroprotectant in its International (application (PCT) and provisional patent. Thus, as a result by mixing natural molecules and generic pharmaceutical drugs with CBD we intend to increase the effectiveness of CBD and improve the treatment of different diseases.
https://globenewswire.com/news-release/2016/1...nt-IP.html
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!